Showing results (3101-3110 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Risk factors and outcomes for steroid-refractory immune-related hepatotoxicity in locally advanced and metastatic cancerSonglin Liu, Yuekai Zhang, Yaping Guan, et al.
Cancer Immunology, Immunotherapy : CII|November 20, 2025
Fruquintinib plus sintilimab in previously bevacizumab-treated, pMMR/MSS refractory metastatic colorectal cancer: a phase 2 clinical trialWen Zhang, Cai-Feng Gong, Jing-Long Huang, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
Research progress in the construction and application of immunotherapy resistance modelsHuiling Li, Shenzhan Wang, Xiaoxi Li, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
Automatically quantifying spatial heterogeneity of immune and tumor hypoxia environment and predicting disease-free survival for patients with rectal cancerShenlun Chen, Zonglin Liu, Jiazhou Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8+CD103+ cDC1 and TRM cell responsesZhaojia Wu, Zhenyu Yang, Tauqeer Iftikhar, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancerRenate Pichler, Josef Fritz, Sarah Maier, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitorsMina Cho, Hyun Chang, Ju Han Kim
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancerHaruka Suzuki, Kohei Hamada, Junzo Hamanishi, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
FcRn-guided antigen trafficking enhances cancer vaccine efficacyMengyu Hong, Muziying Liu, Fang Zhu, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Efficacy and safety of PD-1 blockade-activated neoantigen specific cellular therapy for advanced relapsed non-small cell lung cancerYun Qiao, Kaiyuan Hui, Chenxi Hu, et al.
Pageof 652